Mobicam 0.5% Gel

Introduction

Mobicam is a prescription medication that contains the active ingredient Piroxicam. It is available under the brand name Mobicam. This gel is commonly used to alleviate pain and reduce inflammation associated with various musculoskeletal conditions.

Uses

Mobicam is prescribed to patients who are experiencing pain and inflammation due to conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It can also be used to relieve pain associated with sprains, strains, and other musculoskeletal injuries.

Dosage and Administration

To use Mobicam, apply a thin layer of the gel to the affected area and gently massage it into the skin until it is fully absorbed. The gel should be applied 2-4 times a day, depending on the severity of the pain and inflammation. Wash your hands before and after applying the gel and avoid contact with the eyes, mouth, or broken skin.

Mechanism of Action

The active ingredient in Mobicam, Piroxicam, belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by inhibiting the production of certain substances in the body that cause pain and inflammation. By reducing the levels of these substances, Mobicam helps to relieve pain and reduce swelling in the affected area.

Side Effects

Common side effects may include skin irritation, redness, itching, or a burning sensation at the application site. These side effects are usually mild and resolve on their own. However, if you experience severe skin rash, blistering, or any other unusual or persistent side effects, seek medical attention.

Drug Interactions

Mobicam may interact with certain medications. Inform your healthcare provider about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. Some medications that may interact with Mobicam include:

• Other NSAIDs, such as aspirin or ibuprofen
• Blood thinners, such as warfarin
• Certain medications for high blood pressure, such as ACE inhibitors or diuretics

Precautions

Before using Mobicam, inform your healthcare provider about any medical conditions you have, especially if you have a history of allergic reactions to NSAIDs or if you are pregnant or breastfeeding. Some important precautions to consider include:

• Do not use Mobicam on open wounds, broken skin, or near the eyes, mouth, or mucous membranes.
• Avoid prolonged exposure to sunlight or artificial UV rays while using Mobicam, as it may increase the risk of sunburn.
• If you experience an allergic reaction, such as difficulty breathing, swelling, or hives, discontinue use and seek immediate medical attention.

Storage

Mobicam should be stored at room temperature, away from direct sunlight and moisture. Keep the gel out of reach of children and pets. Do not use the gel if it has expired or if the packaging is damaged.

Patient Tips

• Follow the instructions provided by your healthcare provider regarding the frequency and duration of use.
• Avoid applying excessive amounts of Mobicam, as it may increase the risk of side effects.
• If you forget to apply the gel at the scheduled time, apply it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• If you have any questions or concerns about the use of Mobicam, consult your healthcare provider for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Feldene 10mg Capsules (Health Professionals SmPC) Available at:
• Piroxicam (Drugs.com) [Accessed 17 Jun. 2024] (online) Available at:
• piroxicam (feldene) (RX) [Accessed 19 Jun. 2024] (online) Available at:
• Piroxicam (MedlinePlus) [Accessed 7 Jun. 2024] (online) Available at:
• Mostafa GAE, Al-Dosseri AS, Al-Badr AA. Piroxicam. Profiles Drug Subst Excip Relat Methodol. 2020;45:199-474. doi: 10.1016/bs.podrm.2019.10.007. Epub 2019 Dec 18. [Accessed 20 Jun. 2024] Available at: